Punctal Plugs & Tear Conservation

Tears do not simply sit on the eye until they evaporate. With blinking, tear fluid moves toward tiny openings near the inner corners of the upper and lower eyelids. These openings are called the lacrimal puncta. From there, tears travel through the:

canaliculi→lacrimal sac→nasolacrimal duct→nose

This is why your nose can run when you cry. Your eyes and nose are connected through the lacrimal drainage system. Punctal occlusion interferes with this drainage pathway.

Where Tears Come From

Why Blinking Matters

A punctal plug is a tiny device inserted into the punctum to partially or completely reduce tear drainage. Very simply, in a normal eye:

tear production→ocular surface→drainage

With punctal occlusion:

tear production→ocular surface→reduced drainage

The goal is to allow the tears that are already present to remain on the ocular surface longer. TFOS DEWS III includes tear conservation among the major strategies used to manage dry eye.

Not directly. This distinction is extremely important. Punctal plugs primarily change tear drainage and retention. They do not directly repair the lacrimal gland.

So if someone has aqueous-deficient dry eye because their lacrimal glands produce too little fluid, punctal plugs do not necessarily correct that production problem. Instead, they attempt to make better use of the limited tears that are still being produced.

Think of it as a sink. If the tap is running very slowly, you have two basic options: increase the flow from the tap, or slow the water leaving through the drain. Punctal plugs address the drain.

Stimulating Natural Tear Production: working on the tap instead

They make the most intuitive sense when insufficient tear volume or retention is an important part of the problem. In international clinical-practice data, punctal occlusion is much more strongly associated with treatment of aqueous-deficient dry eye than evaporative dry eye.

This makes biological sense. If someone already has a limited aqueous tear supply, conserving that supply may increase the amount of fluid available on the ocular surface. But this does not mean plugs can only ever be used in pure aqueous deficiency. Dry eye is frequently mixed.

The important question remains: is insufficient tear retention an important treatment target in this particular eye?

Aqueous Deficiency

Not all punctal plugs are designed to behave the same way. Broadly, there are temporary or absorbable plugs and longer-lasting plugs.

Temporary plugs may be made from materials that gradually dissolve. They can sometimes be useful when a clinician wants to see how the eye responds to reduced drainage before considering a longer-lasting approach.

Longer-lasting plugs are often made from materials such as silicone and are designed to remain in place until they are removed or spontaneously extrude. Some plugs sit near the punctal opening. Others are positioned deeper within the canalicular system. Different designs have different practical advantages and potential complications.

Punctal occlusion does not necessarily require a plug. In more severe disease, particularly when plugs repeatedly fall out or when long-term tear conservation is required, the punctum can be closed surgically or with thermal cautery.

This is a much more permanent intervention. The principle is still the same: reduce tear drainage. But unlike inserting a removable plug, permanent occlusion is much less easily reversed. That makes patient selection particularly important.

They can. The older randomized evidence was not especially strong. A Cochrane review identified 18 trials involving 711 participants and concluded that the overall evidence was limited and heterogeneous. Some studies showed improvement, but the review could not establish a clear universal benefit across all dry-eye populations and outcomes.

That uncertainty is important. But it does not mean plugs are ineffective. It means the clinical-trial literature available at the time was relatively small and inconsistent. More recent research continues to provide additional information.

A particularly interesting randomized, sham-controlled trial published in 2026 studied 66 patients with refractory dry eye and ocular-surface damage. The researchers deliberately occluded both upper and lower puncta strongly enough to induce tear overflow. Compared with sham treatment, the punctal-plug group showed significantly greater improvement in symptoms and corneal staining, with differences emerging from around three weeks and continuing during the 24-week study.

That is useful evidence that substantial tear conservation can meaningfully improve both how patients feel and what happens to the ocular surface in appropriately selected patients. But it does not mean every dry-eye patient should have all four puncta blocked. The study investigated a particular population with refractory disease and ocular-surface damage.

Often they do. Because both upper and lower puncta contribute to drainage, partial occlusion can be attempted before complete occlusion. A clinician may therefore begin with the lower puncta and assess the response. If tear retention remains inadequate, additional occlusion may be considered.

This also provides some control over an obvious potential problem: too much tear retention. Because yes, punctal occlusion can work too well.

The result can be epiphora, meaning tears overflowing from the eye. Someone may experience:

• •constant watering
• •tears running down the cheek
• •blurred vision from excessive tear volume
• •or simply an uncomfortable feeling of having too much fluid on the eye

Interestingly, in severe dry eye, some clinical protocols deliberately induce a degree of epiphora because maximizing tear retention is the therapeutic goal. The 2026 randomized trial above intentionally used this approach. So tearing after punctal occlusion is not always evidence that something has gone wrong. But it can also mean the degree of occlusion is greater than that individual needs.

Potentially, yes, depending on why the eyes are watering. This sounds contradictory. But remember that watery eyes can sometimes result from reflex tearing. An unstable or irritated ocular surface may trigger bursts of reflex tear production even when baseline tear-film homeostasis is poor.

So “My eyes water” does not automatically mean “I have plenty of normal tears.” The underlying tear-production pattern and ocular-surface condition matter.

The Schirmer Test: measuring tear production, and its limits

Now the controversial question. This idea comes from a reasonable biological concern. Dry-eye tears can contain elevated levels of inflammatory mediators. If we reduce tear drainage, perhaps we also reduce clearance of those inflammatory molecules. Therefore:

punctal occlusion→inflammatory tears remain longer→more inflammation

It sounds logical, and this concern has influenced clinical practice. But the actual evidence does not support such a simple equation.

A prospective study examined exactly this question. Twenty-nine patients with moderate dry eye received nonabsorbable plugs in both lower puncta. After three weeks, dry-eye symptoms improved significantly and corneal fluorescein staining decreased in most regions. Researchers also measured tear cytokines and MMP-9. And importantly, overall cytokine and MMP-9 levels did not significantly increase after punctal occlusion.

So this study does not support the simplistic idea that punctal plugs inevitably concentrate inflammatory mediators and worsen inflammation.

But there is another side to the result. Inflammatory markers also did not significantly decrease overall. The authors therefore suggested that anti-inflammatory treatment may still be important in patients with inflammatory dry eye.

That is much more nuanced than “Never plug an inflamed eye.”

Researchers subsequently examined broader changes in tear proteins after punctal occlusion. They found two different response patterns. In one group, inflammatory proteins decreased while protective lacrimal proteins increased. In another group, the pattern moved in the opposite direction. Interestingly, patients showing the more favorable protein pattern had lower baseline Schirmer scores.

This suggests something important: the biological response to tear conservation may not be identical in every patient. And it gives us a much more realistic picture than the idea that plugs simply trap “good tears” or “bad tears.” The tear film is a dynamic biological system.

I would not present this as an absolute rule. If clinically significant ocular-surface inflammation is present, treating that inflammation makes sense regardless of whether plugs are being considered. But current evidence does not establish that punctal occlusion must always be delayed until inflammation has completely disappeared. In fact, punctal occlusion itself can improve symptoms and ocular-surface staining even when inflammatory markers are present.

And a randomized study comparing punctal plugs, cyclosporine, and the combination found that combination therapy produced advantages in several clinical and inflammatory measures compared with either strategy alone.

So rather than “inflammation OR plugs,” the more useful clinical question may sometimes be: do we need to improve tear retention AND control inflammation?

Anti-Inflammatory Treatment for Dry Eye

It is biologically possible that altered tear clearance could influence the ocular-surface environment differently in different patients. The proteomic study we just discussed supports the idea that responses are heterogeneous.

So we should not replace one absolute claim (“plugs trap inflammation”) with another (“plugs can never affect inflammation negatively”). The evidence supports neither extreme. Instead, the ocular surface should be monitored after occlusion.

This requires a distinction. Punctal plugs do not treat the meibomian glands themselves. They do not:

• •unblock glands
• •improve meibum quality directly
• •or restore the lipid layer

But someone with MGD can also have inadequate aqueous tears. In that case, punctal occlusion may address the aqueous component of mixed dry eye while another treatment addresses MGD. Again, one patient can have several treatment targets simultaneously.

Meibomian Gland Dysfunction (MGD) — coming soon

This is sometimes suggested because retaining tears does not correct excessive evaporation. But that does not automatically mean plugs worsen evaporative disease. The more accurate statement is that punctal occlusion does not correct the cause of excessive evaporation.

If severe MGD is destabilizing the tear film, simply retaining more aqueous fluid may not solve the problem. The lipid deficiency may still need to be treated separately.

Dry Eye Is Often Mixed

One of the most common is simply that the plug falls out. Plug extrusion can occur, sometimes repeatedly. Other possible problems include:

• •foreign-body sensation
• •irritation
• •excess tearing
• •local inflammation
• •and, less commonly, infection involving the punctum or canalicular system

A plug can also migrate deeper into the drainage pathway, depending on its design. These complications are one reason a tiny plug should not be thought of as a completely trivial intervention.

A poorly positioned or protruding plug can irritate nearby ocular tissues. This can produce foreign-body sensation and local irritation. If a patient develops new discomfort after plug insertion, it should not automatically be interpreted as “my dry eye is getting worse.” The plug itself may need to be examined.

Many silicone punctal plugs can be removed. That is one advantage over permanent punctal closure. If a patient develops:

• •persistent epiphora
• •irritation
• •or another plug-related problem

the clinician may be able to remove the device. This reversibility can also make plugs useful as a way of testing whether tear conservation is helpful before considering permanent occlusion.

Repeated plug loss is not unusual. If punctal occlusion provides substantial benefit but plugs cannot be retained reliably, permanent or semi-permanent approaches may eventually be discussed. But before permanently closing the drainage system, it is useful to know that the patient actually benefits from occlusion and can tolerate increased tear retention.

Not necessarily. Someone may still need artificial tears after punctal occlusion. But if tear retention improves, they may potentially need them less frequently. This can itself be a meaningful treatment outcome. For someone using drops every 20 minutes, reducing that burden can substantially improve daily life even if lubrication is not eliminated completely.

Artificial Tears & Lubricating Eye Drops

Again, start with the target. If the goal is to improve tear retention, useful outcomes include:

• •increased tear volume or tear meniscus
• •less ocular-surface staining
• •reduced need for artificial tears
• •improved comfort
• •improved visual stability
• •and better everyday function

A Schirmer test may also change after occlusion, although interpretation depends on the test method and reflex tearing. The important point is that success does not require “my lacrimal gland now works normally.” That was never what the plug was designed to accomplish.

Then that is useful information. Possible explanations include:

• •aqueous deficiency was not the dominant problem
• •tear retention did not increase enough
• •the plug was lost
• •evaporation remains very high
• •ocular-surface inflammation or damage remains untreated
• •or another contributor is driving symptoms

It does not automatically mean “my dry eye is too severe for plugs.” It may mean that the treatment target was incomplete or incorrect.

That is also useful information. A strong response to tear conservation suggests that insufficient tear volume or excessive loss through drainage was clinically relevant. But again, symptom improvement does not prove that the original cause has disappeared. The lacrimal gland may still produce too little. The plug may simply compensate for that deficiency very effectively. And compensation can be an entirely valid treatment strategy.

Not necessarily. Modern dry-eye management is moving away from a simple ladder in which everyone must fail Treatment A before being allowed Treatment B. TFOS DEWS III emphasizes selecting treatment according to the relevant etiological drivers and dry-eye subtype.

If significant aqueous deficiency is identified early, tear conservation may have a logical role early too. Conversely, someone with predominantly evaporative disease and normal tear volume may have little reason to start with punctal occlusion simply because their symptoms are severe. Severity alone does not identify the correct treatment target.

How to Choose a Dry Eye Treatment